During the corresponding time, Akebia Therapeutics Inc saw a revenue deteriorated by -21.36 % year on year, sequentially revenue fell by -8.25 %. While revenue at the Akebia Therapeutics Inc 's corporate clients
Akebia Therapeutics Inc's Comment on Sales, Marketing and Customers
The company operates in the manufacture and supply of pharmaceutical products, including Vafseo, vadadustat, and Auryxia. It relies on suppliers and contract manufacturing organizations (CMOs) for clinical and commercial supply. Supply agreements for Vafseo are in place with STA Pharmaceutical Hong Kong Limited and Patheon Inc. For Auryxia, the drug substance is supplied by Siegfried Evionnaz SA, and the drug product is supplied by Patheon Manufacturing Services LLC (Thermo Fisher). The company also provides authorized generic supply for Auryxia. The synthesis and formulation processes for vadadustat and Auryxia are described as reliable and reproducible at commercial scale, utilizing proprietary manufacturing methods. Supply risks are managed through inventory control and potential additional manufacturing arrangements.
Akebia Therapeutics Inc’s Comment on Sales, Marketing and Customers
The company operates in the manufacture and supply of pharmaceutical products, including Vafseo, vadadustat, and Auryxia. It relies on suppliers and contract manufacturing organizations (CMOs) for clinical and commercial supply. Supply agreements for Vafseo are in place with STA Pharmaceutical Hong Kong Limited and Patheon Inc. For Auryxia, the drug substance is supplied by Siegfried Evionnaz SA, and the drug product is supplied by Patheon Manufacturing Services LLC (Thermo Fisher). The company also provides authorized generic supply for Auryxia. The synthesis and formulation processes for vadadustat and Auryxia are described as reliable and reproducible at commercial scale, utilizing proprietary manufacturing methods. Supply risks are managed through inventory control and potential additional manufacturing arrangements.
Sources:
Akebia Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Akebia Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Akebia Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
201.02 %